# The Medicines (Products for Human Use) (Fees) Regulations 2016, Regulation 27A: Fee for renewals of a marketing authorisation


Where an application is made to the licensing authority for the renewal of a marketing authorisation in the case of a product for sale or supply in Great Britain and the application for renewal—
(a) relates to a medicinal product which, at the time the marketing authorisation was granted, contained a new active ingredient; and
(b) is the first renewal in relation to that product,
the fee payable by the applicant is the fee prescribed in Part 6 of Schedule 2.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/regulation/27A (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/regulation-27A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.